General

DES Home | For Consumers | For Health Care Providers
For DES Update Partners | Contact Us

Notice! Content may be out of date
The following content is no longer maintained and may be out of date. Persons with disabilities having difficulty accessing the information on this page may contact cdcinfo@cdc.gov for assistance. Please view the Updated Bibliographies on the Updated Bibliographies page for updated information on this topic.


	Consumers Home

	About DES

	DES Research

	What You Can Do

	Additional Resources

	Partner and Government Organizations

	DES Glossary

	DES Bibliography

	Interactive DES Self-Assessment Guide

	Women Prescribed DES While Pregnant

	DES Daughters

	DES Sons





Consumers Home > Additional DES Resources > DES Bibliography > General

General

DES Bibliography

	Overview

	History

	Women Prescribed DES While Pregnant

	Women Exposed to DES Before Birth (in the Womb), Known as DES Daughters

	Men Exposed to DES Before Birth (in the Womb), Known as DES Sons

	Third Generation (Offspring of DES Daughters or Sons)

	Immunology

	Psychology

	Reviews

	General

Cohn BA, Wingard DL, Patterson RC, McPhee SJ, Gerbert B. The National DES Education Program: effectiveness of the California Health Provider Intervention. J Cancer Educ 2002 Spring;17(1):40-5.

Department for Policy Coordination and Sustainable Development. Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by government. 6th ed. Pharmaceuticals. New York: United Nations; 1997.

Federal Drug Administration. Federal Register 1971;36:21537.

Jackson R, O'Donnell L, Johnson C, Dietrich AJ, Lauridsen J, O'Donnell C. Office systems intervention to improve diethylstilbestrol screening in managed care. Obstet Gynecol 2000;96(3):380-4.

Kaufman RH, Adam E, Haynes SG, Herbst AL, Kutzner SK, McPhee SJ, et al. Physician information: how to identify and manage DES exposed individuals. Bethesda, MD: National Cancer Institute; 1995.

National Cancer Institute. Exposure in utero to diethylstilbestrol and related synthetic hormones. JAMA 1976;236(10):1107-9.

National Cancer Institute. Cancer Facts: Questions and Answers about DES. Bethesda, MD: NCI; 2000. Available from: http://cis.nci.nih.gov/fact/3_4.htm.

National Cancer Institute. Dictionary. Available from http://cancer.gov/dictionary/.

National Institutes of Health. DES Research Update. Bethesda, MD: NIH; 1999.

National Cancer Institute, National Institute of Environmental Health Sciences, Office of Research on Women's Health, US Public Health Service's Office on Women's Health, Centers for Disease Control and Prevention. DES research update: Current knowledge, future directions. Proceedings. Bethesda, MD: NIH; 1999.

National Institutes of Health. NIH Workshop: Long-term effects of exposure to diethylstilbestrol (DES). Bethesda, MD: NIH; 1992.

Robboy SJ, Noller KL, Kaufman RH, Barnes AB, Townsend D, Gundersen JH, et al. Information for physicians: an atlas of findings in the human female after intrauterine exposure to diethylstilbestrol. Bethesda, MD: National Institutes of Health; 1983.

Wingard DL, Cohn BA, Helmrich SP, Edelstein SL. DES awareness and exposure: the 1994 California Behavioral Risk Factor Survey. Am J Prev Med 1996;12(5):437-41.